Jae‐Cheol Jo

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis

Seok Jin Kim, Dok Hyun Yoon, Arnaud Jaccard et al. · The Lancet Oncology · 2016 · 386 citations · Full text

Medicine, Clinical Sciences, Oncology +15

Daratumumab plus bortezomib and dexamethasone <i>versus</i> bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR

Andrew Spencer, Suzanne Lentzsch, Katja Weisel et al. · Haematologica · 2018 · 262 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK/T-cell lymphoma, nasal type

Jae‐Cheol Jo, Misung Kim, Yunsuk Choi et al. · Annals of Hematology · 2016 · 111 citations

Veterinary Medicine, Cancer Biology, Oncology +15

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer

Jong‐Mu Sun, Yong Chan Ahn, Eun Kyung Choi et al. · Annals of Oncology · 2013 · 106 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma

Ho‐Young Yhim, Jin Seok Kim, Yeung‐Chul Mun et al. · Biology of Blood and Marrow Transplantation · 2015 · 88 citations · Full text

Medicine, Oncology, Immunotherapy +12